ScoreWhy is Procter & Gamble Health Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.63% and Operating profit at 8.59% over the last 5 years
2
Flat results in Dec 25
- OPERATING CF(Y) Lowest at Rs 224.92 Cr
- PBT LESS OI(Q) At Rs 104.46 cr has Fallen at -11.27%
- PAT(Q) At Rs 77.59 cr has Fallen at -14.6%
3
With ROE of 47.4, it has a Very Expensive valuation with a 13.9 Price to Book Value
- The stock is trading at a fair value compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.21%, its profits have risen by 16.7% ; the PEG ratio of the company is 1.8
- At the current price, the company has a high dividend yield of 4
4
Falling Participation by Institutional Investors
- Institutional investors have decreased their stake by -0.94% over the previous quarter and collectively hold 19.87% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is P & G Health Ltd for you?
Low Risk, Medium Return
Absolute
Risk Adjusted
Volatility
P & G Health Ltd
2.65%
0.13
20.75%
Sensex
-4.15%
-0.31
13.42%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.63%
EBIT Growth (5y)
8.59%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.45
Sales to Capital Employed (avg)
1.80
Tax Ratio
25.73%
Dividend Payout Ratio
88.52%
Pledged Shares
0
Institutional Holding
19.87%
ROCE (avg)
87.52%
ROE (avg)
36.14%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
29
Industry P/E
33
Price to Book Value
13.87
EV to EBIT
21.92
EV to EBITDA
20.68
EV to Capital Employed
24.47
EV to Sales
6.17
PEG Ratio
1.75
Dividend Yield
3.96%
ROCE (Latest)
115.53%
ROE (Latest)
47.36%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
ROCE(HY)
Highest at 65.27%
NET SALES(Q)
At Rs 373.86 cr has Grown at 20.69%
-7What is not working for the Company
OPERATING CF(Y)
Lowest at Rs 224.92 Cr
PBT LESS OI(Q)
At Rs 104.46 cr has Fallen at -11.27%
PAT(Q)
At Rs 77.59 cr has Fallen at -14.6%
Loading Valuation Snapshot...
Here's what is working for P & G Health Ltd
Net Sales - Quarterly
Highest at Rs 373.86 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 373.86 cr has Grown at 20.69%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for P & G Health Ltd
Operating Cash Flow - Annually
Lowest at Rs 224.92 Cr and Fallen
each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 104.46 cr has Fallen at -11.27%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 77.59 cr has Fallen at -14.6%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
